Ken Griffin Qiagen N.V. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$35.55 - $43.57 $43.8 Million - $53.7 Million	1,232,813 Added 138.12%	2,125,364 $92.3 Million
Q3 2023 Nov 14, 2023	SELL	$39.13 - $47.24 $23.1 Million - $27.9 Million	-591,377 Reduced 39.85%	892,551 $36.1 Million
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $62.9 Million - $67 Million	1,431,999 Added 2757.61%	1,483,928 $66.8 Million
Q1 2023 May 15, 2023	SELL	$45.29 - $50.76 $47.4 Million - $53.1 Million	-1,046,806 Reduced 95.27%	51,929 $2.39 Million
Q4 2022 Feb 14, 2023	BUY	$41.91 - $50.48 $30.7 Million - $36.9 Million	731,712 Added 199.36%	1,098,735 $54.8 Million
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $43.7 Million - $53.8 Million	-1,067,695 Reduced 74.42%	367,023 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $8.95 Million - $10.4 Million	-208,158 Reduced 12.67%	1,434,718 $67.7 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $60.8 Million - $78.2 Million	1,440,266 Added 710.86%	1,642,876 $80.5 Million
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $71.2 Million - $79.4 Million	-1,405,571 Reduced 87.4%	202,610 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $54 Million - $66 Million	1,160,957 Added 259.59%	1,608,181 $83.1 Million
Q2 2021 Aug 16, 2021	BUY	$46.28 - $52.75 $15.5 Million - $17.7 Million	334,803 Added 297.81%	447,224 $21.6 Million
Q1 2021 May 17, 2021	SELL	$46.25 - $56.02 $2.77 Million - $3.36 Million	-59,938 Reduced 34.78%	112,421 $5.47 Million
Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $19.1 Million - $22.6 Million	-413,629 Reduced 70.59%	172,359 $9.11 Million
Q3 2020 Nov 16, 2020	SELL	$42.51 - $52.42 $40.1 Million - $49.5 Million	-943,847 Reduced 61.7%	585,988 $30.6 Million
Q2 2020 Aug 14, 2020	BUY	$39.49 - $44.36 $50.4 Million - $56.7 Million	1,277,494 Added 506.26%	1,529,835 $65.5 Million
Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $65.9 Million - $82.6 Million	-1,986,629 Reduced 88.73%	252,341 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $44 Million - $74.7 Million	1,732,781 Added 342.32%	2,238,970 $75.7 Million
Q3 2019 Nov 14, 2019	BUY	$32.73 - $40.81 $13.5 Million - $16.9 Million	413,249 Added 444.64%	506,189 $16.7 Million
Q2 2019 Aug 14, 2019	SELL	$35.73 - $41.39 $6.05 Million - $7.01 Million	-169,412 Reduced 64.57%	92,940 $3.77 Million
Q1 2019 May 15, 2019	SELL	$33.78 - $40.68 $8.18 Million - $9.85 Million	-242,011 Reduced 47.98%	262,352 $0
Q4 2018 Feb 14, 2019	SELL	$32.65 - $37.95 $47.1 Million - $54.8 Million	-1,442,867 Reduced 74.1%	504,363 $17.4 Million
Q3 2018 Nov 13, 2018	BUY	$35.99 - $39.39 $5.17 Million - $5.66 Million	143,676 Added 7.97%	1,947,230 $0
Q2 2018 Aug 10, 2018	BUY	$31.23 - $37.47 $7.47 Million - $8.96 Million	239,253 Added 15.29%	1,803,554 $0
Q1 2018 May 11, 2018	BUY	$31.01 - $34.72 $15.9 Million - $17.8 Million	512,588 Added 48.74%	1,564,301 $50.5 Million
Q4 2017 Feb 09, 2018	BUY	$30.68 - $35.37 $28.7 Million - $33.1 Million	936,936 Added 816.31%	1,051,713 $32.5 Million
Q3 2017 Nov 09, 2017	BUY	$31.02 - $32.94 $3.56 Million - $3.78 Million	114,777	114,777 $3.62 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.34M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$186 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$40.3 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

768K
Shares

$33.2 Million
2.63% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.63 Million
0.01% of portfolio
Bdl Capital Management Paris, I0

88.8K
Shares

$3.84 Million
3.33% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.84B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account